# Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD

> **NCT04879030** · PHASE2,PHASE3 · COMPLETED · sponsor: **Haiphong University of Medicine and Pharmacy** · enrollment: 170 (actual)

## Conditions studied

- COPD Exacerbation Acute

## Interventions

- **DRUG:** Beta-Lactams
- **DRUG:** Fluoroquinolone

## Key facts

- **NCT ID:** NCT04879030
- **Lead sponsor:** Haiphong University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2020-08-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2021-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04879030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04879030, "Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04879030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*